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Abstract
Background—An important challenge in surgical ablation for atrial fibrillation (AF) is the
scarcity of publications on credible predictors of long-term success in procedures performed with
ablation tools that produce consistently reliable transmural lesions. We examined factors
associated with 1-year success and no atrial arrhythmia (AA) recurrence during 1 to 5 years after
surgical ablation for AF.

Author Manuscript

Methods—The study prospectively monitored 743 surgical ablation patients with complete
rhythm follow-up at 12 months after the operation. No detected AA was defined as no known
recurrence of AA, no cardioversions, and no catheter ablations at all available follow-up
assessments.
Results—Patients were a mean age of 64.7 years, and 32% were women. Patients with no
detected AA during the first year after surgical ablation were more likely to maintain sinus rhythm
without recurrence during 1 to 5 years (74% vs 28%, p < 0.001) and to be in sinus rhythm off
medication at 5 years (80% vs 53%, p < 0.001). Mixed-model logistic regression revealed that
lower risk for AA recurrence during 1 to 5 years was associated with no detected AA during the
first 12 months (odds ratio [OR], 0.11; p < 0.001) and surgeon experience with 50 or more cases
(OR, 0.63; p = 0.043), whereas older age (OR, 1.03; p < 0.001) and longer preoperative AF
duration (OR, 1.04; p = 0.043) were associated with greater risk for AA recurrence.
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Conclusions—Most patients with no detected AA throughout the first 12 months after surgical
ablation continued to be recurrence free for 5 years. Younger age, shorter preoperative AF
duration, and greater surgeon experience may be associated with more persistent surgical
correction of AF.
Surgical ablation procedures for atrial fibrillation (AF) have now been performed for 3
decades [1]. However, only a few large studies have reported follow-up of at least 5 years
and used societal guidelines for outcomes and reporting. This unique phenomenon creates a
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challenge in identifying predictors of long-term success to develop credible procedural and
postprocedural management strategies. The evidence is particularly lacking for procedures
performed using ablation tools that produce consistently reliable transmural lesions and
according to well-defined lesion sets.
In previous publications, we reported variables that were associated with success at 2 and 5
years after surgical ablation [2, 3], Investigators from Washington University in St. Louis
reported a good success rate at 5 years after a Cox maze IV procedure with duration of
preoperative AF as one of the predictors for failure [4]. Reported results on predictors for
success after percutaneous catheter ablation clearly demonstrate that early termination of AF
and success over the first few months is associated with higher long-term success with less
requirement for repeated procedures [5].
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The primary purpose of this study was to examine risk factors for recurrence of atrial
arrhythmia during 5 years of follow-up. In particular, we evaluated the role of no detected
atrial arrhythmia throughout the first 12 months after surgical ablation in maintaining sinus
rhythm, freedom from reintervention, and AF-associated complications during 5 years after
the procedure. The secondary purpose of this study was to evaluate whether risk factors for
early atrial arrhythmia recurrence would also emerge as risk factors for late atrial arrhythmia
recurrence.

Patients and Methods
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Within the group of 953 patients who underwent surgical ablation for AF between January
2005 and June 2015, 743 patients reached the 12-month time point after the procedure (not
due: n = 78; died <12 months: n = 46; withdrawn: n = 25; lost to follow-up: n = 61). The
Inova Fairfax Hospital Institutional Review Board (IRB study #06.022 and #12.055)
approved this study and granted a waiver of consent.
Data were collected prospectively before and after surgical ablation on rhythm, clinical
events, and medication status at 3, 6, 9, 12, 18, and 24 months and yearly thereafter [6]. An
institutional protocol guided recommendations for clinical decision making during follow-up
[7, 8]. Data from the local Society of Thoracic Surgeons database were merged with the AF
registry data [9]. The European System for Cardiac Operative Risk Evaluation 2011 revision
(EuroSCORE II) was used to reflect operative risk because The Society of Thoracic
Surgeons risk score is not calculated for surgical ablation cases.
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Rhythm status was available for all patients at 12 months but was not available for all
patients at each time point throughout the first 12 months after surgical ablation. No detected
atrial arrhythmia was defined as no known recurrence of atrial arrhythmia, no follow-up
cardioversions, and no follow-up ablations at all follow-up time points available for each
patient. For the independent variable of no detected atrial arrhythmia by 12 months, this
definition was applied for all time points beyond the blanking period up to and including 12
months after surgical ablation (6 to 12 months). For the primary outcome variable, no
detected atrial arrhythmia more than 1 year after surgical ablation, this definition was
applied for all time points past 1 year and up to and including 5 years after the procedure. By
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5 years postoperatively, 287 patients with rhythm status were available in this sample (not
due: n = 321; died 1 to 5 years: n = 40; withdrawn: n = 29; lost to follow-up: n = 66).
Patients who withdrew or were lost to follow-up did not differ on any patient characteristics
from the patients with rhythm status available at 5 years, except that the patients available
were slightly older (64.2 vs 61.4 years, p = 0.045).
Success was defined according to the Heart Rhythm Society Expert Consensus Statement
Guidelines [10] as sinus rhythm (freedom from atrial arrhythmia >30 seconds) without the
use of class I/III antiarrhythmic drugs (AAD) and verified using 24-hour Holter or
electrocardiogram, or both, at all time points. The proportion of rhythm verified with
electrocardiogram alone ranged from 20% at 6 months to 5% at 60 months, with the values
steadily decreasing throughout follow-up. All other rhythm verification included at least 24hour Holter.
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Surgical Procedure
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The lesion set and energy source were based on surgeon discretion. All surgical ablation
procedures were performed using cardiopulmonary bypass support, whether concomitant or
stand alone, and no hybrid or epicardial beating heart ablations were included. The lesion set
for the cryothermal-only procedures is the traditional Cox maze III procedure, and the lesion
set for the cryothermal combined with bipolar radiofrequency energy procedures is the Cox
maze IV as described by Damiano and colleagues [1, 11, 12]. For cryothermal energy only
the CryoFlex (10 or 10S, Medtronic, Minneapolis, MN) or the Cryo 1 or Cryo 2 (AtriCure,
Inc, Mason, OH) were used. Whether cryothermal energy only or in combination with
bipolar radiofrequency was used, cryolesions were applied for 2 minutes for all lesions,
including those crossing the atrioventricular groove both in the right atrium and left atrium
and the epicardial coronary sinus lesion to complete the left atrial isthmus lesion on the left.
The left atrial appendage was excised or excluded in all cases.
In this series, 11 surgeons performed surgical ablation procedures. Surgeon experience with
surgical ablation was defined as the number of surgical ablation cases performed at our
institution at the time of each procedure in a continuous and chronological format.
Individual procedures were then categorized as having surgeon experience of less than 50
cases or 50 or more cases at the time of the procedure [13].
Statistical Analysis
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All analyses were conducted with SPSS 17.0 software (SPSS Inc, Chicago, IL), and a twotailed p value of less than 0.05 was considered statistically significant. Continuous data are
presented as mean ± SD or median (interquartile range), and categorical data are presented
as frequency (percentage). Group differences on continuous variables were examined using
independent samples t tests or Mann-Whitney U tests, and group differences on categorical
variables were examined using the χ2 or Fisher exact tests, as appropriate.
Kaplan-Meier survival analysis with the log-rank test was used to compare groups on
cumulative survival and freedom from embolic stroke and major bleeding during follow-up.
The American Heart Association definition was used for embolic stroke, and major bleeding
was defined as a bleeding event requiring hospitalization or blood units. Multivariable Cox
Ann Thorac Surg. Author manuscript; available in PMC 2019 May 01.
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regression was conducted to examine the role of stable rhythm up to 1 year on survival after
adjustment for age, sex, EuroSCORE II, and stable rhythm between 1 and 5 years.
Multivariable logistic regression was used to examine risk factors for stable rhythm up to 12
months, including age, sex, left atrial size (cm), duration of AF (years), type of AF defined
by the Heart Rhythm Society (HRS) guidelines (paroxysmal atrial fibrillation [PAF] vs nonPAF), lesion set (full Cox maze vs all others), energy source (cryothermia alone vs all
others), surgeon experience (≥50 cases vs <50 cases), and number of concomitant
procedures.
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A generalized linear mixed model using multivariable binomial logistic regression was
conducted to examine the risk factors for recurrence at more than 1 year and up to 5 years
after surgical ablation. Not all patients in this sample had reached 5 years after surgical
ablation, but the mixed model methodology with random intercepts allowed inclusion of all
available follow-up rhythm data for patients after 1 year and individual-specific random
effects. The fixed effects factors included in this model were selected a priori based on
clinical and theoretical justification and included age, sex, left atrium size (cm), duration of
AF (years), type of AF (PAF vs non-PAF), lesion set (Cox maze vs all others), energy source
(cryothermia alone vs all others), surgeon experience (≥50 cases vs <50 cases), number of
concomitant procedures, and recurrence status up to 12 months [10].

Results
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The patients in this sample were a mean age of 64.7 ± 11.2 years, and 32% were women.
Operative and AF-specific details of the sample included 87% full Cox maze procedures,
20% stand-alone procedures, 37% of patients with persistent AF, and 49% of patients with
longstanding persistent AF. Previous catheter ablations occurred in 16% of patients (41% of
the stand-alone procedures). Surgical ablation was performed using cryothermia alone in
58% of procedures, bipolar radiofrequency alone in 10%, and a combination of the two
energy sources in 32%.
In 68% (503 of 743) of patients, no detected atrial arrhythmia was reported during the first
12 months of follow-up. Compared with the group with detected atrial arrhythmias during
the first 12 months, patients with no recurrences were younger (p = 0.030), had higher
ejection fraction (p = 0.043), shorter duration of AF (p = 0.007), smaller left atrial size (p =
0.016), lower EuroSCORE II operative risk (p = 0.003), and greater median cases of surgeon
experience with surgical ablation as a continuous variable (p = 0.001; Table 1). In addition,
the group with no detected atrial arrhythmia during the first 12 months had a lower
proportion of patients with concomitant tricuspid valve operations (p = 0.027).
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When evaluated in a multivariable analysis, the factors significantly associated with having
no detected atrial arrhythmia during the first 12 months were smaller left atrial size (p =
0.006), shorter duration of AF (p = 0.009), and surgeon experience with 50 or more surgical
ablation cases (p < 0.001; Table 2). Each 1-cm increase in left atrial size and 1-year increase
in AF duration was associated with 22% and 4% reduced odds for stable sinus rhythm
during the first 12 months, respectively. Patients whose procedures were performed by

Ann Thorac Surg. Author manuscript; available in PMC 2019 May 01.

Ad and Holmes

Page 5

Author Manuscript

surgeons with experience of 50 or more cases were close to 2.5-times more likely to have
stable sinus rhythm during the first 12 months.
Late Rhythm Outcomes

Author Manuscript

The median follow-up period was 48 (35 to 79) months. Stable sinus rhythm at all points
after surgical ablation up to 5 years occurred in 52% (388 of 743) of patients. There were
666 patients with follow-up longer than 12 months for late outcome analysis. Of these, 396
(60%) did not experience a documented or reported recurrence and remained off AAD
during the entire 1 to 5 years of follow-up. Assessing success at an individual time point,
70% (202 of 287) of patients were in sinus rhythm off AAD at 5 years. The group with no
recurrences during the first 12 months had significantly higher return to sinus rhythm off
AAD at every follow-up assessment after 12 months (Fig 1), including 2 years (92% vs
48%, p < 0.001), 3 years (89% vs 51%, p < 0.001), 4 years (83% vs 48%, p < 0.001), and 5
years (80% vs 53%, p < 0.001) after surgical ablation. Within the group that experienced
recurrences during the first 12 months, 65 patients never returned to sinus rhythm in 1 to 5
years, 61 remained in sinus rhythm throughout 1 to 5 years, 14 had a recurrence during 1 to
5 years but maintained sinus rhythm afterwards, and the remainder had inconsistent rhythm
status during 1 to 5 years.
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A significant difference between the groups was also found for any recurrence during the
entire 1 to 5 years of follow-up. Specifically, patients with no detected atrial arrhythmia
throughout the first 12 months after surgical ablation were more likely to continue to
maintain sinus rhythm with no detected atrial arrhythmia recurrence throughout the entire
follow-up period of 1 to 5 years (74% vs 28%, p < 0.001). When individual time points up to
1 year were examined, sinus rhythm off AAD at 6 months (90% vs 58%, p < 0.001), 9
months (95% vs 65%, p < 0.001), and 12 months (97% vs 65%, p < 0.001) was higher for
patients who maintained stable sinus rhythm during late follow-up (1 to 5 years) compared
with those who experienced recurrences beyond 1 year.
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Mixed model logistic regression evaluating risk factors for arrhythmia recurrences during 1
to 5 years revealed that greater odds of atrial arrhythmia recurrence was associated with
older age (p < 0.001) and longer preoperative years of AF duration (p = 0.043), whereas
lower odds of atrial arrhythmia recurrence was associated with surgeon experience of 50 or
more surgical ablation cases (p = 0.043) and no detected atrial arrhythmia during the first 12
months (p < 0.001; Table 3). For each year increase in age and duration of AF, there was a
3% and 4% greater risk for atrial arrhythmia recurrence during 1 to 5 years, respectively. In
addition, patients with no detected atrial arrhythmia during the first 12 months after surgical
ablation had 89% lower risk for an atrial arrhythmia recurrence during 1 to 5 years of
follow-up postoperatively. Other factors in the model were not significantly associated with
atrial recurrence during 1 to 5 years, including non-PAF and larger left atrial size.
Late Clinical Outcomes
Patients with no detected atrial arrhythmia during the first year were less likely to remain on
anticoagulation at each late follow-up time point, including 2 years (23% vs 57%, p <
0.001), 3 years (21% vs 61%, p < 0.001), 4 years (20% vs 59%, p < 0.001), and 5 years
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(27% vs 63%, p < 0.001). Freedom from major bleeding events during the first 5 years after
surgical ablation was similar for patients with and without detected atrial arrhythmias during
the first 12 months (89.6% vs 91.6%; log-rank = 0.76, p = 0.382). Similarly, freedom from
embolic stroke during the first 5 years after surgical ablation was similar for patients with
and without detected atrial arrhythmias during the first 12 months (98.8% vs 98.4%; logrank = 0.13, p = 0.714). Although the incidence of embolic stroke was very low, preliminary
analysis found that patients who underwent procedures that used cryothermia energy alone
were less likely to experience an embolic stroke during the first 5 years of follow-up
compared with those with bipolar radiofrequency energy included in the procedure (0.7% vs
2.6%, p = 0.037), regardless of rhythm stability. Mean time to embolic stroke did not differ
between patients with cryothermia energy alone and those whose procedure included bipolar
radiofrequency energy (11 vs 27 months, p = 0.086). Lastly, 5-year cumulative survival did
not differ for patients with and without detected atrial arrhythmias during the first 12 months
in Kaplan-Meier survival analysis (88.1% vs 92.8%; log-rank = 3.16, p = 0.075) or
multivariable Cox regression analysis adjusting for important clinical variables (hazard ratio,
1.67; 95% confidence interval, 0.67 to 4.13; p = 0.270).
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Comment

Author Manuscript

The results of this study demonstrated that surgical ablation for AF was associated with a
relatively high freedom from atrial arrhythmia recurrence during the first 5 years after the
procedure when the definitions of the HRS consensus guidelines for success were used [10].
Primary outcome analyses demonstrated that patients with no atrial arrhythmia during the
first year after surgical ablation were more likely to maintain sinus rhythm during 5 years
thereafter. In addition to the traditional factors of younger age and shorter AF duration,
greater surgeon experience with surgical ablation was associated with stable sinus rhythm
throughout the first 5 years after surgical ablation. Sinus rhythm and discontinuation of
anticoagulation at each follow-up time point were also more likely for patients with no
detected atrial arrhythmia throughout the first year postoperatively.
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Data regarding long-term follow-up are extremely important to the field, and currently, there
are no specific national tools to collect information besides The Society of Thoracic
Surgeons database, which is limited to 30-day outcome. Such data are valuable to better
understand the different variables associated with sustainable success and develop the best
clinical management of patients after surgical ablation for AF. Recurrence of atrial
arrhythmia early after surgical ablation has already been shown to be associated with inferior
long-term success [3]. The same pattern of results is captured in the catheter ablation
literature, where early recurrence, especially late in the blanking period, was strongly
associated with late recurrences [14–16].
The mechanism of early and late recurrence may be completely different. Early recurrence is
likely associated with acute myocardial injury, inflammation, and perhaps changes in
myocardial autonomic innervation, whereas late recurrence is more likely to be related to
reactivation of the arrhythmogenic substrate [17]. In the surgical literature it is evident that
failure of surgical ablation for AF is associated with age, duration of AF, left atrium size,
and AF type to some extent, especially with limited lesion sets [18–20].
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Our findings suggest that some of the variables associated with long-term failure are also
associated with short-term atrial arrhythmia recurrences during the first 12 months. This
information is especially important in regards to surgical training and earlier intervention.
Early recurrence of arrhythmia after surgical ablation was found to be an important risk
factor for late failure at our center and at Washington University in St. Louis [3, 18].
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Unlike studies of catheter ablation techniques, which are mainly based on stand-alone
procedures and failures are readily studied for electrophysiological mechanisms, most
patients are not electrophysiologically studied after surgical ablation and are usually patients
who have undergone surgical ablation concomitant with another procedure rather than a
stand-alone procedure. This fact may be very important, because many different techniques
and technologies are applied in concomitant procedures that complicate our ability to study
and understand failures. Identifying other potential modifiers of success associated with
concomitant procedures is also essential. For instance, in structural heart disease (ie, mitral
valve insufficiency repaired together with surgical ablation), there are no data on the
potential effect of the mitral valve repair longevity on long-term success of surgical ablation.
Future research should examine specific methods of maintaining sinus rhythm during the
first year, including surgical training, to increase the effect on atrial reverse remodeling and
perhaps the longevity of surgical ablation. To that end, the clear HRS Consensus Statement
Guidelines defining success as sinus rhythm off AAD may force clinicians to discontinue
AAD early for patients in sinus rhythm who are older and have a long history of AF, even
though they may benefit from longer duration of AAD and freedom from atrial arrhythmia
recurrences.
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Age, duration of AF, surgeon experience, and lack of early recurrences were associated with
later recurrences independent of lesion set, which was not significantly associated with late
recurrence in the mixed model analysis. This study was not designed to answer this
important question under debate in the field, because patients were not randomized to
different ablation and lesion set schemes. Also, patients who had left atrial-only lesion sets
were different from those who had Cox maze procedures, reflecting our approach to patient
selection for surgical ablation (Fig 2). These results emphasize the importance of selecting
the appropriate patients for each lesion set based on preoperative characteristics, particularly
for AF-specific factors. When decision making is applied appropriately, the lesion set may
not affect the success of the procedure [21].
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Surgical training in ablation is not mandated or structured, which results in a wide variation
of surgical competency. This issue is sensitive but needs to be addressed on a societal level,
and surgical ablation for AF should be approached like other surgical procedures with clear
definitions for surgical training [13]. This is a key required step in standardizing surgical
approaches to treat AF. It is reasonable to assume that better training and experience in
surgical ablation will translate into better outcomes, as demonstrated for other surgical
procedures and more recently with mitral valve repair [22]. We were able to show that in a
large-volume center, differences in outcome throughout follow-up exist and are associated
with surgical experience as captured by number of cases performed at the time of the
indexed surgical ablation procedure. Today, there are no specific thresholds in surgeon
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education, training, or experience before performing surgical ablation, but should be
formalized [13, 23].
Limitations
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A limitation of this study is the format of rhythm status data collection. Although these data
were collected in accordance with HRS Guidelines, rhythm status was not continuously
monitored. It is possible that patients in sinus rhythm at all reported time points may still
have experienced episodes of atrial arrhythmia recurrence that were not captured. However,
an ideal monitoring strategy is not yet identified, because implantable devices that
continuously monitor heart rhythm have shown high false positives, and recent studies have
clearly demonstrated that there is no advantage over HRS recommended follow-up [24].
Even the Reveal LINQ (Medtronic, Minneapolis, Minnesota) is limited in patients with very
low AF burden, which represents patients after the Cox maze procedure [25]. In addition,
use of mixed model logistic regression analysis in this study allowed the inclusion of all
available follow-up rhythm data during 1 to 5 years after surgical ablation and accounted for
individual-specific effects that might affect this type of repeated outcome assessment.
In addition, the results from this study with highly experienced surgeons and this particular
group of patients may not be generalizable to other centers. It is imperative that surgeons
electing to perform surgical ablation are experienced. Further research into which patients
benefit most from surgical ablation will improve the success of the procedure by informing
decision making for patient selection because currently, there is no standardization in this
process.
Conclusions

Author Manuscript
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This study demonstrated that no detected atrial arrhythmia during the first 12 months after
surgical ablation for AF has an important association with stable rhythm throughout followup and long-term success. The study does not necessarily suggest that failure to achieve
freedom from early recurrence will result in failure during late follow-up, but clearly, some
patients may experience significant recurrences. Those recurrences of atrial arrhythmia may
be associated with higher rates of AADs, oral anticoagulation therapy, reduced quality of
life, and increased risk for embolic strokes. Early and late outcomes were associated with
duration of AF and surgical experience; therefore, earlier intervention and training may be
valuable in improving the success of surgical ablation. Future studies should focus on
gaining a deeper understanding of the surgical technique and energy source as well as a
more tailored follow-up approach in patients with higher risk for recurrence, including
number of office visits and antiarrhythmic strategies to maximize short-term and long-term
success.
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Fig. 1.

Comparison of patients with and without detected atrial arrhythmias (AA) up to 12 months
(12M) on the proportion of patients in sinus rhythm off antiarrhythmic drugs at 1.5, 2, 3, 4,
and 5 years after surgical ablation.
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Fig. 2.

Comparison of full Cox maze and limited lesion sets on clinical characteristics of patients
that appear to affect surgeon decision making for appropriate lesion set. All differences
between lesion sets are statistically significant. (AF = atrial fibrillation; LA = left atrium;
LSPAF = long-standing persistent atrial fibrillation; PAF = paroxysmal atrial fibrillation.)

Author Manuscript
Author Manuscript
Ann Thorac Surg. Author manuscript; available in PMC 2019 May 01.

Ad and Holmes

Page 13

Table 1

Author Manuscript

Patient Characteristics
AA Recurrence During 12 Months
Characteristica
Age, y
Female
Body mass index, kg/m2
Ejection fraction

Yes (n = 240)

No (n = 503)

p

66.0 ± 11.8

64.1 ± 10.8

0.030

87 (36)

147 (29)

0.054

28.6 ± 6.2

28.1 ± 5.5

0.303

0.538 ± 0.114

0.556 ± 0.106

0.043

Diabetes

42 (18)

75 (15)

0.365

Hypertension

156 (65)

324 (64)

0.876

17 (7)

30 (6)

0.558

Peripheral vascular disease

Author Manuscript

Previous cerebrovascular accident

16 (7)

36 (7)

0.806

Chronic pulmonary disease

49 (20)

80 (16)

0.129

Duration of AF, mo

27 (5–82)

19 (3–55)

0.007

Left atrium size, cm

5.1 ± 1.0

4.9 ± 1.0

0.016

Nonparoxysmal AF type

214 (89)

425 (85)

0.086

Previous catheter ablation

36 (15)

80 (16)

0.751

EuroSCORE II, %

4.5 ± 4.7

3.4 ± 4.3

0.003

Elective status

215 (90)

426 (85)

0.070

Cryothermia only energy source

129 (54)

302 (60)

0.104

Full Cox maze lesion set

210 (88)

433 (86)

0.597

130.5 (26–369.5)

218 (64–415)

0.001

CABG

61 (25)

141 (28)

0.454

Mitral valve

122 (51)

233 (46)

0.250

Aortic valve

49 (20)

96 (19)

0.669

Tricuspid valve

47 (20)

67 (13)

0.027

Cases of surgeon experience,b No.
Concomitant surgical proceduresc

Author Manuscript

a

Continuous data are presented as mean ± SD or median (interquartile range) and categorical data as frequency (%).

b

All cases of experience with surgical ablation for each surgeon at our institution.

c

Categories are not mutually exclusive.

AA = atrial arrhythmia; AF = atrial fibrillation; CABG = coronary artery bypass grafting; EuroSCORE II = European System for Cardiac Operative
Risk Evaluation 2011 revision.
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Logistic Regression Results Predicting Stable Sinus Rhythm During the First 12 Months After Surgical
Ablation
p

Factor

OR

95% CI

Left atrium size, cm

0.78

0.65–0.93

Duration of AF, y

0.96

0.92–0.99

0.009

Surgeon experience ≥50 cases

2.42

1.57–3.73

<0.001

Age, y

0.99

0.97–1.002

0.078

Female

0.73

0.50–1.05

0.089

Nonparoxysmal AF

0.61

0.35–1.09

0.095

Cryothermia only energy source

0.99

0.68–1.46

0.971

Full Cox maze lesion set

0.95

0.53–1.69

0.861

2

0.92

0.55–1.52

0.731

≥3

1.05

0.62–1.79

0.853

0.006

Surgical procedures,a No.

Author Manuscript

a

Reference group = stand alone procedures.

AF = atrial fibrillation; CI = confidence interval; OR = odds ratio.
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Mixed Model Logistic Regression Results Predicting Atrial Arrhythmia Recurrence Between 1 and 5 Years
p

Factor

OR

95% CI

No detected AA up to 1 year

0.11

0.08–0.16

<0.001

Age, y

1.03

1.02–1.05

<0.001

Duration of AF, y

1.04

1.001–1.07

0.043

Surgeon experience ≥50 cases

0.63

0.41–0.99

0.043

Female

1.03

0.70–1.51

0.888

Nonparoxysmal AF

0.77

0.43–1.37

0.374

Left atrium size (cm)

1.20

0.998–1.45

0.052

Cryothermia only energy source

0.68

0.46–1.01

0.056

Full Cox maze lesion set

1.53

0.84–2.80

0.165

2

0.78

0.46–1.32

0.357

≥3

1.07

0.62–1.85

0.811

Surgical procedures,a No.

Author Manuscript

a

Reference group = stand alone procedures.

AA = atrial arrhythmia; AF = atrial fibrillation; CI = confidence interval; OR = odds ratio.
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